The Long-Term Relationship between a Real Change in Prostate Volume and a Significant Change in Lower Urinary Tract Symptom Severity in Population-Based Men: The Krimpen Study
| Autor: | Frans P.M.J. Groeneveld, Chris H. Bangma, Arthur M. Bohnen, J.L.H. Ruud Bosch |
|---|---|
| Přispěvatelé: | General Practice, Urology |
| Rok vydání: | 2008 |
| Předmět: |
Male
medicine.medical_specialty Urology Population Prostatic Hyperplasia Statistics Nonparametric Lower urinary tract symptoms Prostate Surveys and Questionnaires Internal medicine Humans Medicine Longitudinal Studies skin and connective tissue diseases education Aged Ultrasonography Gynecology education.field_of_study Chi-Square Distribution Genitourinary system business.industry Organ Size Odds ratio Middle Aged medicine.disease medicine.anatomical_structure Disease Progression International Prostate Symptom Score sense organs business Chi-squared distribution Progressive disease |
| Zdroj: | European Urology, 53(4), 819-827. Elsevier |
| ISSN: | 0302-2838 |
| Popis: | Objective: We used the database of a longitudinal community-based study to investigate whether real changes in prostate volume (PV) (ie, changes greater than the combination of intra- and interobserver variation of volume measurement) corresponded with significant changes in symptom severity. Methods: In a community-based study of men aged 50-78 yr, the International Prostate Symptom Score (IPSS) and PV were measured at baseline and at 4.2-yr follow-up. Of 1417 men, 864 completed both rounds. A significant change in IPSS was defined as a change of >= 4 points. A real change in PV was defined as a percent change of >= 26%, or an absolute change of >= 10 cc. Results: After 4.2 yr, about 20% of the men had experienced a significant increase in IPSS and 16-23% had a real increase in PV. The age-adjusted odds ratio for a significant increase in symptom severity, which contrasts men who have a real increase in PV and men who do not show such an increase, is 1.38 (95%CI, 1.05-1.85). The age-adjusted odds ratio for a significant decrease in symptom severity, which contrasts men with a real increase in PV and those without such an increase, is 1.50 (95%CI, 1.11-2.85). Conclusions: Benign prostatic hyperplasia can be characterised as a progressive disease in a certain proportion of men older than 50 yr. Men with growing prostates are at a greater risk of symptomatic deterioration. Men who have prostates that do not grow significantly are more likely to improve symptomatically. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect